Literature DB >> 2767678

Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.

B Porfirio1, G Ambroso, G Giannella, G Isacchi, B Dallapiccola.   

Abstract

The action of the iron chelator desferrioxamine (DFO) on the cytogenetic pattern of cultured lymphocytes from Fanconi anemia (FA) patients was investigated. The addition of 10(-4) M DFO throughout the culture time resulted in a 50% reduction of the spontaneous chromosome breakage of FA cells. In addition, the clastogenic action of diepoxybutane on FA lymphocytes was also partly counteracted by DFO. The above findings support the assumption that one of the mechanisms involved in the pathogenesis of FA might be an impaired capacity of the cells from such patients to remove active oxygen species. The relationship between intraleukocyte chelatable iron pool and free radical formation in FA subjects is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767678     DOI: 10.1007/BF00274146

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

Authors:  H KEBERLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

2.  [Occurrence of ferritin in serum].

Authors:  F WOHLER; F SCHOMLAU
Journal:  Klin Wochenschr       Date:  1959-04-15

3.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens.

Authors:  A D Auerbach; S R Wolman
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

Review 4.  Prooxidant states and tumor promotion.

Authors:  P A Cerutti
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

5.  Effects of iron overload on lipid peroxide formation and oxidative demethylation by the liver endoplasmic reticulum.

Authors:  E D Wills
Journal:  Biochem Pharmacol       Date:  1972-01-15       Impact factor: 5.858

6.  Increased activity of glutathione S-transferase and fast decay of reduced glutathione in Fanconi's anemia erythrocytes.

Authors:  B Dallapiccola; M Magnani; G Novelli; F Mandelli
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

7.  Erythrocyte superoxide-dismutase deficiency in Fanconi's anaemia.

Authors:  H Joenje; A W Eriksson; R R Frants; F Arwert; B Houwen
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

8.  Bovine superoxide dismutase in Fanconi anaemia. Therapeutic trial in two patients.

Authors:  V Izakovic; E Strbáková; E Kaiserová; P Krizan
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Antioxidant status of Fanconi anemia fibroblasts.

Authors:  J J Gille; H M Wortelboer; H Joenje
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

10.  Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes.

Authors:  B Dallapiccola; B Porfirio; V Mokini; G Alimena; G Isacchi; E Gandini
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

View more
  3 in total

1.  Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.

Authors:  M Poot; H Hoehn
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

2.  Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine.

Authors:  Filipa Ponte; Rosa Sousa; Ana Paula Fernandes; Cristina Gonçalves; José Barbot; Félix Carvalho; Beatriz Porto
Journal:  Orphanet J Rare Dis       Date:  2012-05-16       Impact factor: 4.123

3.  Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia.

Authors:  Sudit S Mukhopadhyay; Kathryn S Leung; M John Hicks; Philip J Hastings; Hagop Youssoufian; Sharon E Plon
Journal:  J Cell Biol       Date:  2006-10-23       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.